Rare Cancers: Clinical Trials
2026-06-21 · Department of Health and Social Care · HL1179 · Official question
Question
To ask His Majesty's Government what assessment they have made of the United Kingdom’s capability to participate in EU-wide and international clinical trials for rare cancers.
Answer
The Government recognises that international collaboration is essential for clinical trials in rare cancers, where small and geographically dispersed patient populations mean that multi-country studies are necessary to generate robust clinical evidence.Th...